Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1402152-13-9
Purity
95%
Copanlisib is a medication used to treat relapsed follicular lymphoma. It is a selective pan-Class I phosphoinositide 3-kinase inhibitor. The active ingredient in Aliqopa intravenous therapy is copanlisib dihydrochloride.
Properties
Name
Copanlisib dihydrochloride
Smiles
Cl.Cl.COC=1C(OCCCN2CCOCC2)=CC=C3C4=NCCN4C(=NC13)NC(=O)C=5C=NC(N)=NC5
Targets
Please log in to see this information
copanlisib | copanlisib dihydrochloride
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$120
2 mg
$180
5 mg
$300
10 mg
$520
15 mg
$POA
20 mg
$680
25 mg
$840
30 mg
$1000
35 mg
$1160
40 mg
$1320
45 mg
$1480
50 mg
$1640
75 mg
$2880
100 mg
$POA
Quantity
1
Total amount
$ 300
copanlisib | copanlisib dihydrochloride
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.